Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal

Journal of Neuroendocrinology

Volumn 19, Issue 3, 2007, Pages 198-207

  Vining, C ^a   Iyer, V ^a   Bhatnagar, Seema ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ACTH; Corticosterone; Repeated stress

Indexed keywords

ALPHA HELICAL CORTICOTROPIN RELEASING FACTOR[9-41]; ASTRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; ENDOCRINE FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; CHRONIC DISEASE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; MALE; PEPTIDE FRAGMENTS; PITUITARY-ADRENAL SYSTEM; PRACTICE (PSYCHOLOGY); RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 33846798115     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2006.01522.x     Document Type: Article

References (65)

1. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW. Corticotropin releasing factor (CRF) binding protein: A novel regulator of CRF and related peptides. Front Neuroendocrinol 1995; 16: 362-382.
2. Grigoriadis DE, Lovenberg TW, Chalmers DT, Liaw C, De Souza EB. Characterization of corticotropin-releasing factor receptor subtypes. Ann NY Acad Sci 1996; 780: 60-80.
3. De Souza EB. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995; 20: 789-819.
4. Rivier C, Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 1983; 305: 325-327.
5. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-1397.
6. Dunn AJ, Berridge CW. Physiological and behavioural responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 1990; 15: 71-100.
7. Kalin NH, Sherman JE, Takahashi LK. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res 1988; 457: 130-135.
8. Korte SM, Bouws GA, Bohus B. Central actions of corticotropin-releasing hormone (CRH) on behavioral, neuroendocrine, and cardiovascular regulation: Brain corticoid receptor involvement. Horm Behav 1993; 27: 167-183.
9. Reul JM, Labeur MS, Wiegers GJ, Linthorst AC. Altered neuroimmunoendocrine communication during a condition of repeatedly increased brain corticotropin-releasing hormone drive. Ann NY Acad Sci 1988; 840: 444-455.
10. van Gaalen MM, Stenzel-Poore MP, Holsboer F, Steckler T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci 2002; 15: 2007-2015.
11. Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology 2002; 160: 113-121.
12. Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ. Repeated administration of the selective corticotropin-releasing factor 1 receptor antagonist CP154,526: Behavioral, endocrine and neurochemical effects in the rat. J Pharmacol Exp Ther 2000; 294: 588-597.
13. Britton KT, Lee G, Vale W, Rivier J, Koob GF. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic'actions of CRF in the rat. Brain Res 1986; 369: 303-306.
14. Korte SM, Korte-Bouws GA, Bohus B, Koob GF. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiol Behav 1994; 56: 115-120.
15. Grillon C, Southwick SM, Charney DS. The psychobiological basis of posttraumatic stress disorder. Mol Psychiatry 1996; 1: 278-297.
16. Bhatnagar S, Huber R, Nowak N, Trotter P. Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J Neuroendocrinol 2002; 14: 403-410.
17. Jaferi A, Nowak N, Bhatnagar S. Negative feedback functions in repeatedly stressed rats: Role of posterior paraventricular thalamus. Physiol Behav 2003; 78: 365-373.
18. Viau V, Sawchenko PE. Hypophysiotropic neurons of the paraventricular nucleus respond in spatially, temporally and phenotypically differentiated manners to acute vs. repeated restraint stress. J Comparative Neurol 2002; 445: 293-307.
19. Pitman DL, Ottenweller JE, Natelson BH. Plasma corticosterone levels during repeated presentation of two intensities of restraint stress: repeated stress and habituation. Physiol Behav 1988; 43: 47-55.
20. Akana SF, Hanson ES, Horsley CJ, Strack AM, Bhatnagar S, Bradbury MJ, Milligan ED, Dallman MF. Clamped corticosterone (B) reveals the effect of endogenous B on both facilitated responsivity to acute restraint and metabolic responses to repeated stress. Stress 1996; 1: 33-49.
21. Bhatnagar S, Dallman M. Neuroanatomical basis for facilitation of hypothalamic-pituitary adrenal responses to a novel stressor after repeated stress. Neuroscience 1998; 84: 1025-1039.
22. Bhatnagar S, Meaney MJ. Hypothalamic-pituitary-adrenal function in repeated intermittently cold-stressed neonatally handled and non-handled rats. J Neuroendocrinol 1995; 7: 97-108.
23. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, Strack AM. Stress feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 1992; 4: 517-526.
24. Hauger RL, Lorang M, Irwin M, Aguilera G. CRF receptor regulation and sensitization of ACTH responses to acute ether stress during repeated intermittent immobilization stress. Brain Res 1990; 532: 34-40.
25. Ottenweller JE, Natelson BH, Pitman DL, Drastal SD. Adrenocortical and behavioral responses to repeated stressors: Toward an animal model of repeated stress and stress-related mental illness. Biol Psychiatry 1989; 26: 829-841.
26. Dallman MF, Jones MT. Corticosteroid feedback control of ACTH secretion: effect of stress-induced corticosterone secretion on subsequent stress responses in the rat. Endocrinology 1973; 92: 1367-1375.
27. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N. Regulation of ACTH secretion: Variations on a theme of B. Recent Prog Hormone Res 1987; 43: 113-167.
28. Bhatnagar S, Huber R, Lazar E, Pych L, Vining C. Repeated stress alters behavior in the conditioned defensive burying test: Role of the posterior paraventricular thalamus. Pharmacol Biochem Behav 2003; 76: 343-349.
29. Korte SM. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci Biobehav Rev 2003; 25: 117-142.
30. Stout SC, Owens MJ, Nemeroff CB. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and repeated antidepressant treatment. J Pharmacol Exp Ther 2002; 300: 1085-1092.
31. Bonaz B, Rivest S. Effect of a repeated stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am J Physiol 1998; 275: R1438-R1449.
32. Wiersma A, Baauw AD, Bohus B, Koolhaas JM. Behavioural activation produced by CRH but not alpha-helical CRH (CRH-receptor antagonist when microinfused into the central nucleus of the amygdala under stress free conditions. Psychoneuroendocrinology 1995; 20: 423-432.
33. Buwalda B, de Boer SF, Van Kalkeren AA, Koolhaas JM. Physiological and behavioral effects of repeated intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 1997; 22: 297-309.
34. Menzaghi F, Heinrichs SC, Pich EM, Weiss S, Koob GF. The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress. Corticotropin-releasing factor and cytokines: Role in the stress response. NY Acad Sci 1993; 697: 142-154.
35. Krahn DD, Gosnell BA, Grace M, Levine AS. CRF antagonist partially reverses CRF- and stress-induced effects on feeding. Brain Res Bull 1986; 17: 285-289.
36. Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 1992; 581: 190-197.
37. Berridge CW, Dunn AJ. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Horm Behav 1987; 21: 393-401.
38. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT. CRF antagonist reverses the 'anxiogenic'response to ethanol withdrawal in the rat. Psychopharmacology 1991; 103: 227-232.
39. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 1994; 269: 564-572.
40. Rainnie DG, Fernhout BJ, Shinnick-Gallagher P. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro. J Pharmacol Exp Ther 1992; 263: 846-858.
41. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 4th edn. Boston, MA: Academic Press, 1998.
42. Bhatnagar S, Dallman MJ. The paraventricular nucleus of the thalamus alters rhythms in core temperature and energy balance in a state-dependent manner. Brain Res 1999; 851: 66-75.
43. Bhatnagar S, Viau V, Chu A, Soriano L, Meijer OC, Dallman MF. A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in repeatedly stressed rats and regulates hypothalamic-pituitary-adrenal function. J Neuroscience 2000; 20: 5564-5573.
44. Vahl T, Ulrich-Lai Y, Ostrander M, Dolgas CM, Elfers EE, Seeley RJ, D'Alessio DA, Herman JP. Comparative analysis of ACTH and corticosterone sampling methods in rats. Am J Physiol Endocrinol Metab 2005; 289: E823-E828.
45. Rivier J, Rivier C, Vale W. Synthetic competitive antagonists of corticotropin-releasing factor: Effect on ACTH secretion in the rat. Science 1984; 224: 889-891.
46. Rivier C, Rivier J, Lee S. Importance of pituitary and brain receptors for corticotropin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Brain Res 1996; 721: 83-90.
47. Jones DNC, Kortekaas R, Hatcher PD, Middlemiss DN, White A, Hagan JJ. Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF. Eur J Pharmacol 1999; 373: 141-145.
48. Morimoto A, Nakamori T, Morimoto K, Tan N, Murakami N. The central role of corticotrophin releasing factor (CRF-41) in psychological stress in rats. J Physiol 1993; 460: 221-229.
49. Smagin GN, Howell LA, Redmann S, Ryan DH, Harris RB. Prevention of stress-induced weight loss by third ventricle CRF receptor antagonist. Am J Physiol 1999; 276: R1461-R1468.
50. DeVries AC, Taymans SE, Sundstrom JM, Pert A. Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by corticotropin-releasing factor. Brain Res 1998; 786: 39-46.
51. Smagin GN, Harris RBS, Ryan DH. Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci Lett 1996; 220: 167-170.
52. Basso AM, Spina M, Rivier J, Vale W, Koob GF. Corticotropin-releasing factor antagonist attenuates the 'anxiogenic-like'effect in the defensive burying paradigm but not in the elevated plus-maze following repeated cocaine in rats. Psychopharmacology 1999; 145: 2130.
53. Zorrilla EP, Schulteis G, Ormsby A, Klaassen AL, Ling N, McCarthy JR, Koob GF, De Souza EB. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): Mediation by CRF 1 receptors. Brain Res 2002; 952: 200-210.
54. Turnbull AV, Rivier CL. Intracerebroventricular passive immunization. II. Intracerebroventricular infusion of neuropeptide antisera can inhibit neuropeptide signaling in peripheral tissues. Endocrinology 1998; 139: 128-136.
55. Crawley JN, Fiske SM, Durieux C, Derrien M, Roques BP. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. J Pharmacol Exp Ther 1991; 257: 1076-1080.
56. Nagaraja TN, Patel P, Gorski M, Gorevic PD, Patlak CS, Fenstermacher JD. In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain. Cerebrospinal Fluid Res 2005; 2: 5.
57. Behan DP, Grigoriadis DE, Lovenber T, Chalmers D, Heinrichs S, Liaw C, De Souza EB. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders. Mol Psychiatry 1996; 1: 265-277.
58. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000; 24: 410-414.
59. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24: 403-409.
60. Jezova D, Ochedalsi T, Glickman M, Kiss A, Aguilera A. Central corticotropin-releasing hormone receptorsm odulae hypothalamic pituitary adrenocortical and sympathoadrenal activity during stress. Neuroscience 1999; 94: 797-802.
61. Pisarchuk A, Slominki AT. Alternative splicing of CRH-R1 receptors in human and mouse skin: Identification of new variants and their differential expression. FASEB J 2001; 15: 2754-2756.
62. Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: Implications for physiology and pathophysiology. Endocrine Rev 2006; 27: 260-286.
63. Curtis AL, Pavcovich LA, Grigoriadis DE, Valentino RJ. Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus. Neuroscience 1995; 65: 541-550.
64. Curtis AL, Pavcovich LA, Valentino RJ. Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress. J Pharmacol Exp Ther 1999; 289: 1211-1219.
65. Herman JP, Cullinan WE. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997; 20: 78-84.